Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 4:26 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 542248 | NSE: DECCAN

Deccan Health Care Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹3.58Overvalued by 52.27%vs CMP ₹7.50

P/E (8.4) × ROE (1.2%) × BV (₹44.00) × DY (2.00%)

₹16.73Undervalued by 123.07%vs CMP ₹7.50
MoS: +55.2% (Strong)Confidence: 53/100 (Moderate)Models: 6 Under, 3 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹4.8123%Over (-35.9%)
Graham NumberEarnings₹29.5217%Under (+293.6%)
Earnings PowerEarnings₹3.2311%Over (-56.9%)
DCFCash Flow₹21.2311%Under (+183.1%)
Net Asset ValueAssets₹43.947%Under (+485.9%)
EV/EBITDAEnterprise₹21.879%Under (+191.6%)
Earnings YieldEarnings₹8.807%Under (+17.3%)
ROCE CapitalReturns₹2.897%Over (-61.5%)
Revenue MultipleRevenue₹30.296%Under (+303.9%)
Consensus (9 models)₹16.73100%Undervalued
Key Drivers: EPS CAGR 34.5% lifts DCF — verify sustainability. | ROE 1.2% is below cost of equity.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 34.5%

*Investments are subject to market risks

Investment Snapshot

58
Deccan Health Care Ltd scores 58/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health58/100 · Moderate
ROCE 1.7% WeakROE 1.2% WeakD/E 0.01 Low debtInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money50/100 · Moderate
Promoter holding at 18.4% Stable
Earnings Quality30/100 · Weak
OPM contracting (11% → 5%) DecliningWorking capital: 424 days Capital intensive
Quarterly Momentum100/100 · Strong
Revenue (4Q): +28% YoY AcceleratingProfit (4Q): +83% YoY StrongOPM: 7.3% (up 4.4% YoY) Margin expansion
Industry Rank55/100 · Moderate
P/E 8.4 vs industry 75.2 Cheaper than peersROCE 1.7% vs industry 14.7% Below peersROE 1.2% vs industry 13.9% Below peers3Y sales CAGR: 31% High growth

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Deccan Health Care Ltd Investor Signals

Computed from valuation, cash flow, balance sheet, ownership and quarterly trend data already available in this stock page.

Value Trap Score
70/100
High
Derived from: Cheapness + weak quality + weak cash support
Current data: P/E 8.4 vs Ind 75.2 | ROCE 1.7% | ROE 1.2% | CFO/NP N/A
Balance Sheet Stress
20/100
Comfortable
Derived from: Leverage + debt servicing + liquidity + debt trend
Current data: D/E 0.01x | IntCov 0.0x | Current 5.23x | Borrow/Reserve 0.02x
Cash Flow Reliability
43/100
Mixed
Derived from: Cash backing of earnings + working capital pressure
Current data: CFO ₹0 Cr | NP ₹1 Cr | CFO/NP N/A
Ownership Accumulation
0
Neutral
Derived from: FII + DII + promoter direction, adjusted by crowding
Current data: FII N/A | DII 0.00 pp | Prom 0.00 pp
Business Momentum
+2
Watch closely
Derived from: Latest quarter sales + profit + OPM change
Current data: Q Sales -5.6% | Q NP +5.6% | Q OPM +0.3 pp
Derived FieldValueHow it is derived
Valuation Gap %+123.1%((Fair Value - CMP) / CMP) × 100
Borrowings / Reserves0.02xLatest borrowings divided by latest reserves
CFO / Net ProfitN/ALatest operating cash flow divided by latest net profit
FII ChangeN/ALatest FII% minus previous FII%
DII Change0.00 ppLatest DII% minus previous DII%
Promoter Change0.00 ppLatest promoter% minus previous promoter%
Shareholder Count Change+183Latest shareholder count minus previous count
Quarterly Sales Change-5.6%Latest quarter sales vs previous quarter sales
Quarterly Profit Change+5.6%Latest quarter net profit vs previous quarter net profit
Quarterly OPM Change+0.3 ppLatest quarter OPM minus previous quarter OPM

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 4:26 am

Market Cap 18.6 Cr.
Current Price 7.50
Intrinsic Value₹16.73
High / Low 24.4/6.65
Stock P/E8.44
Book Value 44.0
Dividend Yield0.00 %
ROCE1.69 %
ROE1.18 %
Face Value 10.0
PEG Ratio0.24

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Deccan Health Care Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Deccan Health Care Ltd 18.6 Cr. 7.50 24.4/6.658.44 44.00.00 %1.69 %1.18 % 10.0
Fortis Malar Hospitals Ltd 85.4 Cr. 45.6 98.7/40.818.8 18.30.00 %0.83 %0.56 % 10.0
Indraprastha Medical Corporation Ltd 3,664 Cr. 400 641/32220.0 71.81.13 %39.1 %30.0 % 10.0
Artemis Medicare Services Ltd 3,528 Cr. 223 306/20335.5 56.00.20 %14.9 %12.9 % 1.00
Dr Lal Pathlabs Ltd 22,178 Cr. 1,324 1,771/1,17640.4 1430.91 %28.9 %24.3 % 10.0
Industry Average26,819.31 Cr611.5975.1783.710.36%14.71%13.91%9.04

All Competitor Stocks of Deccan Health Care Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 8.6515.8611.2217.1915.3415.9715.0618.8220.4320.8221.4724.4023.03
Expenses 8.8315.0710.4016.1614.1015.3114.1917.7019.8320.1920.7522.6921.35
Operating Profit -0.180.790.821.031.240.660.871.120.600.630.721.711.68
OPM % -2.08%4.98%7.31%5.99%8.08%4.13%5.78%5.95%2.94%3.03%3.35%7.01%7.29%
Other Income 0.010.010.010.000.000.010.000.000.000.000.010.000.00
Interest 0.040.030.020.000.020.020.020.030.020.020.020.160.04
Depreciation 0.360.360.390.320.400.360.360.370.370.360.410.330.35
Profit before tax -0.570.410.420.710.820.290.490.720.210.250.301.221.29
Tax % -24.56%26.83%26.19%25.35%32.93%58.62%26.53%25.00%23.81%44.00%30.00%26.23%26.36%
Net Profit -0.430.310.310.530.550.130.370.540.160.140.210.900.95
EPS in Rs -0.250.180.180.310.270.060.180.260.070.060.080.360.38

Last Updated: March 3, 2026, 11:04 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 27, 2026, 3:40 am

MetricMar 2009Mar 2010Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 29.2639.5216.1629.3437.8344.2542.2433.7833.1745.0259.7375.1389.72
Expenses 28.2838.549.8116.5423.7727.4430.5731.7427.5442.9755.9771.9584.98
Operating Profit 0.980.986.3512.8014.0616.8111.672.045.632.053.763.184.74
OPM % 3.35%2.48%39.29%43.63%37.17%37.99%27.63%6.04%16.97%4.55%6.29%4.23%5.28%
Other Income 0.090.09-0.170.052.070.080.060.06-3.460.020.010.010.01
Interest 0.010.101.482.141.501.040.180.110.150.110.060.070.24
Depreciation 0.020.221.151.191.281.291.421.471.471.431.471.451.45
Profit before tax 1.040.753.559.5213.3514.5610.130.520.550.532.241.673.06
Tax % 17.31%30.67%0.28%-0.21%-0.15%0.62%0.39%25.00%40.00%26.42%32.59%28.14%
Net Profit 0.860.533.549.5413.3614.4810.090.390.320.401.521.202.20
EPS in Rs 1.610.993.397.389.909.226.420.250.200.230.750.510.88
Dividend Payout % 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2009-20102016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)-38.37%169.49%40.04%8.38%-30.32%-96.13%-17.95%25.00%280.00%-21.05%
Change in YoY Net Profit Growth (%)0.00%207.86%-129.45%-31.66%-38.70%-65.82%78.19%42.95%255.00%-301.05%

Deccan Health Care Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2009-2010 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:%
5 Years:12%
3 Years:31%
TTM:28%
Compounded Profit Growth
10 Years:%
5 Years:-35%
3 Years:-20%
TTM:-34%
Stock Price CAGR
10 Years:%
5 Years:-14%
3 Years:-15%
1 Year:-33%
Return on Equity
10 Years:%
5 Years:1%
3 Years:1%
Last Year:1%

Last Updated: September 5, 2025, 3:11 pm

Balance Sheet

Last Updated: December 4, 2025, 2:43 am

MonthMar 2009Mar 2010Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 5.335.3310.4312.9313.5015.7115.7115.7115.7117.0420.3823.4324.75
Reserves 1.2411.08-2.039.2132.6850.4360.5260.9161.2364.6176.6683.1384.21
Borrowings 0.0010.4613.9410.9410.901.411.301.031.251.551.411.151.33
Other Liabilities 3.023.297.0016.5113.4015.3015.4614.6112.4413.288.8716.2225.90
Total Liabilities 9.5930.1629.3449.5970.4882.8592.9992.2690.6396.48107.32123.93136.19
Fixed Assets 0.0818.5417.1217.3217.7120.8521.2519.8718.5316.8515.6914.3813.69
CWIP 0.000.000.000.003.510.000.000.070.000.000.000.000.00
Investments 0.000.000.000.020.000.000.000.010.010.010.010.010.01
Other Assets 9.5111.6212.2232.2549.2662.0071.7472.3172.0979.6291.62109.54122.49
Total Assets 9.5930.1629.3449.5970.4882.8592.9992.2690.6396.48107.32123.93136.19

Reserves and Borrowings Chart

Cash Flow

MonthMar 2009Mar 2010Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 0.000.003.042.2812.922.622.680.22-0.57-6.59-12.48-6.60
Cash from Investing Activity + 0.000.000.00-1.40-12.90-11.53-1.94-0.08-0.050.26-0.30-0.14
Cash from Financing Activity + 0.000.00-2.91-0.950.2113.07-1.77-0.370.075.0613.648.01
Net Cash Flow 0.000.000.13-0.080.234.16-1.03-0.23-0.55-1.270.861.27
Free Cash Flow 0.000.003.040.887.741.700.870.06-0.63-6.34-12.79-6.74
CFO/OP 0%0%48%18%92%16%23%18%-6%-311%-332%-207%

Free Cash Flow

MonthMar 2009Mar 2010Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow0.98-9.48-7.591.863.1615.4010.371.014.380.502.352.03

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2009Mar 2010Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 52.3950.24181.82229.90170.49159.86177.66134.74141.0797.2160.4461.26
Inventory Days 48.3334.08269.62432.36596.97773.64825.88890.811,182.75683.64445.05326.33
Days Payable 42.9631.06264.36447.94173.22185.88153.84112.09146.00123.2841.3968.52
Cash Conversion Cycle 57.7653.25187.08214.32594.24747.62849.70913.461,177.82657.58464.10319.07
Working Capital Days 55.5151.72-155.17193.82240.82321.94421.77545.99603.01502.26477.19423.69
ROCE %5.08%42.08%32.94%25.03%14.21%0.81%5.62%0.79%2.53%1.69%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 22.21%19.27%19.27%16.12%16.12%16.12%15.66%18.26%19.46%18.42%18.42%18.42%
DIIs 7.80%7.80%7.80%6.53%6.53%6.53%6.34%5.87%5.68%5.37%5.37%5.37%
Public 70.00%72.92%72.92%77.35%77.35%77.35%78.02%75.89%74.87%76.20%76.21%76.20%
No. of Shareholders 8971,1161,6452,0412,7373,0023,1543,4163,6143,6673,7433,926

Shareholding Pattern Chart

No. of Shareholders

Deccan Health Care Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 0.540.800.220.210.25
Diluted EPS (Rs.) 0.450.800.220.210.25
Cash EPS (Rs.) 1.111.451.051.141.18
Book Value[Excl.RevalReserv]/Share (Rs.) 45.4247.5647.8648.9748.76
Book Value[Incl.RevalReserv]/Share (Rs.) 45.4247.5647.8648.9748.76
Revenue From Operations / Share (Rs.) 32.0429.3126.4221.1121.49
PBDIT / Share (Rs.) 1.351.851.213.541.33
PBIT / Share (Rs.) 0.721.130.362.610.39
PBT / Share (Rs.) 0.691.090.300.340.33
Net Profit / Share (Rs.) 0.490.730.210.200.24
NP After MI And SOA / Share (Rs.) 0.490.730.210.200.24
PBDIT Margin (%) 4.206.304.5616.786.19
PBIT Margin (%) 2.273.841.3912.341.85
PBT Margin (%) 2.173.701.141.631.53
Net Profit Margin (%) 1.542.490.800.971.15
NP After MI And SOA Margin (%) 1.542.490.800.971.15
Return on Networth / Equity (%) 1.081.540.440.410.50
Return on Capital Employeed (%) 1.562.280.735.100.78
Return On Assets (%) 0.921.380.370.350.42
Long Term Debt / Equity (X) 0.010.010.010.010.01
Total Debt / Equity (X) 0.010.010.010.010.01
Asset Turnover Ratio (%) 0.640.580.480.360.00
Current Ratio (X) 6.7711.766.336.485.23
Quick Ratio (X) 4.055.672.432.051.69
Inventory Turnover Ratio (X) 1.700.650.680.080.00
Interest Coverage Ratio (X) 42.5544.3018.7436.6719.40
Interest Coverage Ratio (Post Tax) (X) 16.6218.564.3225.524.61
Enterprise Value (Cr.) 37.2755.5746.6254.4643.64
EV / Net Operating Revenue (X) 0.490.931.041.641.29
EV / EBITDA (X) 11.8114.7622.709.7820.85
MarketCap / Net Operating Revenue (X) 0.520.941.041.691.37
Price / BV (X) 0.370.580.570.730.60
Price / Net Operating Revenue (X) 0.520.941.041.691.37
EarningsYield 0.020.020.010.010.01

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Deccan Health Care Ltd. is a Public Limited Listed company incorporated on 14/01/1996 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L72200TG1996PLC024351 and registration number is 024351. Currently Company is involved in the business activities of Manufacture of `ayurvedic' or `unani' pharmaceutical preparation. Company's Total Operating Revenue is Rs. 75.13 Cr. and Equity Capital is Rs. 23.43 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Hospitals & Medical Services6-3-347/17/5/A/Back Position, Hyderabad Telangana 500082Contact not found
Management
NamePosition Held
Dr. Minto Purshotam GuptaManaging Director
Ms. Bhavika SanghaniDirector
Ms. Meenakshi GuptaDirector
Mr. Ravi RamprasadDirector
Mr. Umanja Venkata Satya Siva SriharikollaDirector
Ms. Samhitha KandlakuntaIndependent Director
Ms. Ruchi KhattarIndependent Director
Mr. Viraj Shaileshkumar ShahIndependent Director

FAQ

What is the intrinsic value of Deccan Health Care Ltd and is it undervalued?

As of 05 April 2026, Deccan Health Care Ltd's intrinsic value is ₹16.73, which is 123.07% higher than the current market price of ₹7.50, suggesting the stock is undervalued. This is calculated using the PE ratio method factoring in ROE (1.18 %), book value (₹44.0), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Deccan Health Care Ltd?

Deccan Health Care Ltd is trading at ₹7.50 as of 05 April 2026, with a FY2026-2027 high of ₹24.4 and low of ₹6.65. The stock is currently near its 52-week low. Market cap stands at ₹18.6 Cr..

How does Deccan Health Care Ltd's P/E ratio compare to its industry?

Deccan Health Care Ltd has a P/E ratio of 8.44, which is below the industry average of 75.17. Trading at a steep discount to peers could signal a value opportunity or reflect concerns about the company's fundamentals.

Is Deccan Health Care Ltd financially healthy?

Key indicators for Deccan Health Care Ltd: ROCE of 1.69 % is on the lower side compared to the industry average of 14.71%; ROE of 1.18 % is below ideal levels (industry average: 13.91%). Dividend yield is 0.00 %.

Is Deccan Health Care Ltd profitable and how is the profit trend?

Deccan Health Care Ltd reported a net profit of ₹1 Cr in Mar 2025 on revenue of ₹75 Cr. Compared to ₹0 Cr in Mar 2022, the net profit shows an improving trend.

Does Deccan Health Care Ltd pay dividends?

Deccan Health Care Ltd has a dividend yield of 0.00 % at the current price of ₹7.50. The company is currently not paying meaningful dividends.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Deccan Health Care Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports